相似文献
1
BRAZILIAN CONSENSUS FOR MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 3: CONTROVERSIES AND UNRESECTABLE METASTASES.
Arq Bras Cir Dig. 2016 Jul-Sep;29(3):173-179. doi: 10.1590/0102-6720201600030011.
2
Integrating radioembolization with chemotherapy in the treatment paradigm for unresectable colorectal liver metastases.
Am J Clin Oncol. 2012 Jun;35(3):293-301. doi: 10.1097/COC.0b013e3182005747.
3
I BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 2: APPROACH TO RESECTABLE METASTASES.
Arq Bras Cir Dig. 2016 Mar;29(1):9-13. doi: 10.1590/0102-6720201600010003.
4
FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION.
Arq Bras Cir Dig. 2015 Nov-Dec;28(4):222-30. doi: 10.1590/S0102-6720201500040002.
5
I BRAZILIAN CONSENSUS FOR MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES.
Arq Bras Cir Dig. 2015 Nov-Dec;28(4):221. doi: 10.1590/S0102-6720201500040001.
6
Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour.
Eur J Surg Oncol. 2007 Dec;33 Suppl 2:S76-83. doi: 10.1016/j.ejso.2007.09.016. Epub 2007 Nov 19.
7
Liver transplantation in a patient with unresectable colorectal liver metastases -- a case report.
Chirurgia (Bucur). 2013 Sep-Oct;108(5):719-24.
8
Management of hepatic metastasis from colorectal cancers: an update.
J Hepatobiliary Pancreat Surg. 2008;15(6):570-80. doi: 10.1007/s00534-008-1350-x. Epub 2008 Nov 7.
9
Treatment options for liver metastases from colorectal cancer.
J Exp Clin Cancer Res. 2003 Dec;22(4 Suppl):149-56.
10
Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
Ann Surg Oncol. 2014 Jun;21 Suppl 3:S405-13. doi: 10.1245/s10434-014-3577-x. Epub 2014 Feb 26.
引用本文的文献
1
HEPATOCELLULAR CARCINOMA: DIAGNOSIS AND OPERATIVE MANAGEMENT.
Arq Bras Cir Dig. 2017 Oct-Dec;30(4):272-278. doi: 10.1590/0102-6720201700040011.
本文引用的文献
1
FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION.
Arq Bras Cir Dig. 2015 Nov-Dec;28(4):222-30. doi: 10.1590/S0102-6720201500040002.
2
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.
Lancet Oncol. 2014 Sep;15(10):1065-75. doi: 10.1016/S1470-2045(14)70330-4. Epub 2014 Jul 31.
3
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
Lancet Oncol. 2014 Jul;15(8):862-73. doi: 10.1016/S1470-2045(14)70227-X. Epub 2014 Jun 11.
4
Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease.
Eur J Cancer. 2014 Jul;50(10):1747-1757. doi: 10.1016/j.ejca.2014.03.277. Epub 2014 Apr 21.
5
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study.
Lancet Oncol. 2014 May;15(6):569-79. doi: 10.1016/S1470-2045(14)70118-4. Epub 2014 Apr 14.
6
Defined criteria for resectability improves rates of secondary resection after systemic therapy for liver limited metastatic colorectal cancer.
Eur J Cancer. 2014 Jun;50(9):1590-601. doi: 10.1016/j.ejca.2014.02.024. Epub 2014 Mar 21.
7
EURECCA consensus conference highlights about colon & rectal cancer multidisciplinary management: the radiology experts review.
Eur J Surg Oncol. 2014 Apr;40(4):469-75. doi: 10.1016/j.ejso.2013.10.029. Epub 2013 Dec 14.
8
Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation.
World J Gastroenterol. 2013 Dec 14;19(46):8502-14. doi: 10.3748/wjg.v19.i46.8502.
9
Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal and hepatic metastases: a case-control study.
J Gastrointest Oncol. 2013 Dec;4(4):388-96. doi: 10.3978/j.issn.2078-6891.2013.026.
10
Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.
N Engl J Med. 2013 Sep 12;369(11):1023-34. doi: 10.1056/NEJMoa1305275.
Zotero 插件